JP5648783B2 - Novel lipase and method for synthesizing functional lipids using the same - Google Patents
Novel lipase and method for synthesizing functional lipids using the same Download PDFInfo
- Publication number
- JP5648783B2 JP5648783B2 JP2010110684A JP2010110684A JP5648783B2 JP 5648783 B2 JP5648783 B2 JP 5648783B2 JP 2010110684 A JP2010110684 A JP 2010110684A JP 2010110684 A JP2010110684 A JP 2010110684A JP 5648783 B2 JP5648783 B2 JP 5648783B2
- Authority
- JP
- Japan
- Prior art keywords
- lipase
- acid
- activity
- glycerol
- fatty acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000004367 Lipase Substances 0.000 title claims description 62
- 102000004882 Lipase Human genes 0.000 title claims description 61
- 108090001060 Lipase Proteins 0.000 title claims description 61
- 235000019421 lipase Nutrition 0.000 title claims description 61
- 150000002632 lipids Chemical class 0.000 title claims description 19
- 230000002194 synthesizing effect Effects 0.000 title claims description 11
- 238000000034 method Methods 0.000 title claims description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerol group Chemical group OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 71
- 235000021122 unsaturated fatty acids Nutrition 0.000 claims description 13
- 150000004670 unsaturated fatty acids Chemical class 0.000 claims description 13
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 claims description 9
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 claims description 8
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 claims description 6
- 241000235575 Mortierella Species 0.000 claims description 5
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 claims description 4
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 claims description 4
- 235000021342 arachidonic acid Nutrition 0.000 claims description 4
- 229940114079 arachidonic acid Drugs 0.000 claims description 4
- 230000003197 catalytic effect Effects 0.000 claims description 4
- 238000012258 culturing Methods 0.000 claims description 4
- 235000020673 eicosapentaenoic acid Nutrition 0.000 claims description 4
- 229960005135 eicosapentaenoic acid Drugs 0.000 claims description 4
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 claims description 4
- 235000020669 docosahexaenoic acid Nutrition 0.000 claims description 3
- HOBAELRKJCKHQD-UHFFFAOYSA-N (8Z,11Z,14Z)-8,11,14-eicosatrienoic acid Natural products CCCCCC=CCC=CCC=CCCCCCCC(O)=O HOBAELRKJCKHQD-UHFFFAOYSA-N 0.000 claims description 2
- 235000021298 Dihomo-γ-linolenic acid Nutrition 0.000 claims description 2
- 241001558147 Mortierella sp. Species 0.000 claims description 2
- HOBAELRKJCKHQD-QNEBEIHSSA-N dihomo-γ-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCCCC(O)=O HOBAELRKJCKHQD-QNEBEIHSSA-N 0.000 claims description 2
- 229940090949 docosahexaenoic acid Drugs 0.000 claims description 2
- 230000000694 effects Effects 0.000 description 26
- 235000011187 glycerol Nutrition 0.000 description 22
- 235000014113 dietary fatty acids Nutrition 0.000 description 17
- 229930195729 fatty acid Natural products 0.000 description 17
- 239000000194 fatty acid Substances 0.000 description 17
- 150000004665 fatty acids Chemical class 0.000 description 15
- 235000019626 lipase activity Nutrition 0.000 description 12
- 238000009482 thermal adhesion granulation Methods 0.000 description 11
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 9
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 8
- 239000000758 substrate Substances 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 7
- 239000012228 culture supernatant Substances 0.000 description 7
- 230000007062 hydrolysis Effects 0.000 description 7
- 238000006460 hydrolysis reaction Methods 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 239000003921 oil Substances 0.000 description 7
- 235000019198 oils Nutrition 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- 239000004480 active ingredient Substances 0.000 description 6
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 6
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 6
- 235000011130 ammonium sulphate Nutrition 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 238000003786 synthesis reaction Methods 0.000 description 6
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 5
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 5
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 5
- 239000005642 Oleic acid Substances 0.000 description 5
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 238000005119 centrifugation Methods 0.000 description 5
- 239000003925 fat Substances 0.000 description 5
- 235000019197 fats Nutrition 0.000 description 5
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 5
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 5
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 4
- UPWGQKDVAURUGE-KTKRTIGZSA-N 2-oleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC(CO)CO UPWGQKDVAURUGE-KTKRTIGZSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- -1 etc. Chemical compound 0.000 description 4
- 235000021588 free fatty acids Nutrition 0.000 description 4
- 238000001840 matrix-assisted laser desorption--ionisation time-of-flight mass spectrometry Methods 0.000 description 4
- 239000004006 olive oil Substances 0.000 description 4
- 235000008390 olive oil Nutrition 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- DUCVQOXJVCRDDH-UHFFFAOYSA-N (2-acetyloxy-3-hydroxypropyl) tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CO)OC(C)=O DUCVQOXJVCRDDH-UHFFFAOYSA-N 0.000 description 3
- AFSHUZFNMVJNKX-CLFAGFIQSA-N 1,2-dioleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCC\C=C/CCCCCCCC AFSHUZFNMVJNKX-CLFAGFIQSA-N 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- NHTMVDHEPJAVLT-UHFFFAOYSA-N Isooctane Chemical compound CC(C)CC(C)(C)C NHTMVDHEPJAVLT-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- JVSWJIKNEAIKJW-UHFFFAOYSA-N dimethyl-hexane Natural products CCCCCC(C)C JVSWJIKNEAIKJW-UHFFFAOYSA-N 0.000 description 3
- 238000010828 elution Methods 0.000 description 3
- 238000002523 gelfiltration Methods 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 235000014593 oils and fats Nutrition 0.000 description 3
- 239000008363 phosphate buffer Substances 0.000 description 3
- 230000035790 physiological processes and functions Effects 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 239000001149 (9Z,12Z)-octadeca-9,12-dienoate Substances 0.000 description 2
- DRAWQKGUORNASA-CLFAGFIQSA-N 1,3-dioleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)COC(=O)CCCCCCC\C=C/CCCCCCCC DRAWQKGUORNASA-CLFAGFIQSA-N 0.000 description 2
- GFAZGHREJPXDMH-UHFFFAOYSA-N 1,3-dipalmitoylglycerol Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(O)COC(=O)CCCCCCCCCCCCCCC GFAZGHREJPXDMH-UHFFFAOYSA-N 0.000 description 2
- USPSDZQQNLMVMK-UHFFFAOYSA-N 1-Monolinolein Natural products CCCCCC=CC=CCCCCCCCC(=O)OCC(O)CO USPSDZQQNLMVMK-UHFFFAOYSA-N 0.000 description 2
- WECGLUPZRHILCT-GSNKCQISSA-N 1-linoleoyl-sn-glycerol Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OC[C@@H](O)CO WECGLUPZRHILCT-GSNKCQISSA-N 0.000 description 2
- RZRNAYUHWVFMIP-QJRAZLAKSA-N 1-oleoyl-sn-glycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)CO RZRNAYUHWVFMIP-QJRAZLAKSA-N 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 2
- WXTMDXOMEHJXQO-UHFFFAOYSA-N 2,5-dihydroxybenzoic acid Chemical group OC(=O)C1=CC(O)=CC=C1O WXTMDXOMEHJXQO-UHFFFAOYSA-N 0.000 description 2
- UMCMPZBLKLEWAF-BCTGSCMUSA-N 3-[(3-cholamidopropyl)dimethylammonio]propane-1-sulfonate Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCC[N+](C)(C)CCCS([O-])(=O)=O)C)[C@@]2(C)[C@@H](O)C1 UMCMPZBLKLEWAF-BCTGSCMUSA-N 0.000 description 2
- DRAWQKGUORNASA-UHFFFAOYSA-N Anticancer Glycerol Ester PMV70P691-119 Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(O)COC(=O)CCCCCCCC=CCCCCCCCC DRAWQKGUORNASA-UHFFFAOYSA-N 0.000 description 2
- 229920002261 Corn starch Polymers 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 229920002271 DEAE-Sepharose Polymers 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 229920002684 Sepharose Polymers 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 239000012505 Superdex™ Substances 0.000 description 2
- BAECOWNUKCLBPZ-HIUWNOOHSA-N Triolein Natural products O([C@H](OCC(=O)CCCCCCC/C=C\CCCCCCCC)COC(=O)CCCCCCC/C=C\CCCCCCCC)C(=O)CCCCCCC/C=C\CCCCCCCC BAECOWNUKCLBPZ-HIUWNOOHSA-N 0.000 description 2
- PHYFQTYBJUILEZ-UHFFFAOYSA-N Trioleoylglycerol Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC PHYFQTYBJUILEZ-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 125000002252 acyl group Chemical group 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 2
- 235000015165 citric acid Nutrition 0.000 description 2
- 229910000365 copper sulfate Inorganic materials 0.000 description 2
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 2
- OPQARKPSCNTWTJ-UHFFFAOYSA-L copper(ii) acetate Chemical compound [Cu+2].CC([O-])=O.CC([O-])=O OPQARKPSCNTWTJ-UHFFFAOYSA-L 0.000 description 2
- 239000008120 corn starch Substances 0.000 description 2
- YGNOYUCUPMACDT-UHFFFAOYSA-N dimethylsulfamic acid Chemical compound CN(C)S(O)(=O)=O YGNOYUCUPMACDT-UHFFFAOYSA-N 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 235000019387 fatty acid methyl ester Nutrition 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 239000002198 insoluble material Substances 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 235000021388 linseed oil Nutrition 0.000 description 2
- 239000000944 linseed oil Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 150000003904 phospholipids Chemical class 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- GHBFNMLVSPCDGN-UHFFFAOYSA-N rac-1-monooctanoylglycerol Chemical compound CCCCCCCC(=O)OCC(O)CO GHBFNMLVSPCDGN-UHFFFAOYSA-N 0.000 description 2
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- PHYFQTYBJUILEZ-IUPFWZBJSA-N triolein Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC PHYFQTYBJUILEZ-IUPFWZBJSA-N 0.000 description 2
- 229940117972 triolein Drugs 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 239000011800 void material Substances 0.000 description 2
- DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 description 1
- WTTJVINHCBCLGX-UHFFFAOYSA-N (9trans,12cis)-methyl linoleate Natural products CCCCCC=CCC=CCCCCCCCC(=O)OC WTTJVINHCBCLGX-UHFFFAOYSA-N 0.000 description 1
- MQGBAQLIFKSMEM-MAZCIEHSSA-N 1,2-dilinoleoylglycerol Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC MQGBAQLIFKSMEM-MAZCIEHSSA-N 0.000 description 1
- AFSHUZFNMVJNKX-LLWMBOQKSA-N 1,2-dioleoyl-sn-glycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](CO)OC(=O)CCCCCCC\C=C/CCCCCCCC AFSHUZFNMVJNKX-LLWMBOQKSA-N 0.000 description 1
- DMBAVJVECSKEPF-UHFFFAOYSA-N 1,3-dioctanoylglycerol Chemical compound CCCCCCCC(=O)OCC(O)COC(=O)CCCCCCC DMBAVJVECSKEPF-UHFFFAOYSA-N 0.000 description 1
- RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 description 1
- DVWSXZIHSUZZKJ-UHFFFAOYSA-N 18:3n-3 Natural products CCC=CCC=CCC=CCCCCCCCC(=O)OC DVWSXZIHSUZZKJ-UHFFFAOYSA-N 0.000 description 1
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 1
- IVLXQGJVBGMLRR-UHFFFAOYSA-N 2-aminoacetic acid;hydron;chloride Chemical compound Cl.NCC(O)=O IVLXQGJVBGMLRR-UHFFFAOYSA-N 0.000 description 1
- LNJCGNRKWOHFFV-UHFFFAOYSA-N 3-(2-hydroxyethylsulfanyl)propanenitrile Chemical compound OCCSCCC#N LNJCGNRKWOHFFV-UHFFFAOYSA-N 0.000 description 1
- AGNTUZCMJBTHOG-UHFFFAOYSA-N 3-[3-(2,3-dihydroxypropoxy)-2-hydroxypropoxy]propane-1,2-diol Chemical group OCC(O)COCC(O)COCC(O)CO AGNTUZCMJBTHOG-UHFFFAOYSA-N 0.000 description 1
- GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- JGFBQFKZKSSODQ-UHFFFAOYSA-N Isothiocyanatocyclopropane Chemical compound S=C=NC1CC1 JGFBQFKZKSSODQ-UHFFFAOYSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- PKIXXJPMNDDDOS-UHFFFAOYSA-N Methyl linoleate Natural products CCCCC=CCCC=CCCCCCCCC(=O)OC PKIXXJPMNDDDOS-UHFFFAOYSA-N 0.000 description 1
- 102000005398 Monoacylglycerol Lipase Human genes 0.000 description 1
- 108020002334 Monoacylglycerol lipase Proteins 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 241001661641 Verrucosa Species 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 239000008351 acetate buffer Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical class CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- PWLNAUNEAKQYLH-UHFFFAOYSA-N butyric acid octyl ester Natural products CCCCCCCCOC(=O)CCC PWLNAUNEAKQYLH-UHFFFAOYSA-N 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 150000001982 diacylglycerols Chemical class 0.000 description 1
- 235000013681 dietary sucrose Nutrition 0.000 description 1
- KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 229960002733 gamolenic acid Drugs 0.000 description 1
- RZRNAYUHWVFMIP-HXUWFJFHSA-N glycerol monolinoleate Natural products CCCCCCCCC=CCCCCCCCC(=O)OC[C@H](O)CO RZRNAYUHWVFMIP-HXUWFJFHSA-N 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 210000004020 intracellular membrane Anatomy 0.000 description 1
- 229910000358 iron sulfate Inorganic materials 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 238000006317 isomerization reaction Methods 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000000816 matrix-assisted laser desorption--ionisation Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- DVWSXZIHSUZZKJ-YSTUJMKBSA-N methyl linolenate Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(=O)OC DVWSXZIHSUZZKJ-YSTUJMKBSA-N 0.000 description 1
- JZMJDSHXVKJFKW-UHFFFAOYSA-N methyl sulfate Chemical compound COS(O)(=O)=O JZMJDSHXVKJFKW-UHFFFAOYSA-N 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 150000002759 monoacylglycerols Chemical class 0.000 description 1
- 229940074096 monoolein Drugs 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- UUIQMZJEGPQKFD-UHFFFAOYSA-N n-butyric acid methyl ester Natural products CCCC(=O)OC UUIQMZJEGPQKFD-UHFFFAOYSA-N 0.000 description 1
- 125000001477 organic nitrogen group Chemical group 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000004317 sodium nitrate Substances 0.000 description 1
- 235000010344 sodium nitrate Nutrition 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- CIJQGPVMMRXSQW-UHFFFAOYSA-M sodium;2-aminoacetic acid;hydroxide Chemical compound O.[Na+].NCC([O-])=O CIJQGPVMMRXSQW-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 229940001941 soy protein Drugs 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000002569 water oil cream Substances 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/52—Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts
Description
本発明は、新規リパーゼ及びこれを用いた機能性脂質の合成方法に関する。 The present invention relates to a novel lipase and a method for synthesizing functional lipids using the same.
ヒトを含めた後生動物には自身の生理代謝過程に必須であっても、自身では合成できない脂肪酸の分子種がある。ヒトにとっては、高度不飽和脂肪酸が必須脂肪酸であり、自身では合成できない高度不飽和脂肪酸を合成する他の生物を食物として摂取することで補っている。 Metazoans including humans have molecular species of fatty acids that are essential for their physiological metabolic processes but cannot be synthesized by themselves. For humans, polyunsaturated fatty acids are essential fatty acids and supplemented by ingesting other organisms that synthesize polyunsaturated fatty acids that cannot be synthesized by themselves as food.
高度不飽和脂肪酸は、例えば魚油等、動物性油脂に多く存在しており、グリセロールの2位に高度不飽和脂肪酸が結合した油脂が生物に対して生理活性を与えている。この2位に高度不飽和脂肪酸が結合した油脂を工業的に合成することが望まれており、リパーゼ等の酵素を用いて、グリセロールの2位に高度不飽和脂肪酸が結合した油脂を合成することが試みられている。 Polyunsaturated fatty acids are abundant in animal fats and oils such as fish oil, and fats and oils in which polyunsaturated fatty acids are bonded to the 2-position of glycerol give biological activity to living organisms. It is desired to industrially synthesize oils and fats with highly unsaturated fatty acids bound to the 2-position, and to synthesize fats and oils with highly unsaturated fatty acids bound to the 2-position of glycerol using an enzyme such as lipase. Has been tried.
リパーゼは油脂の分解、合成に作用する酵素として知られており、各種油脂の製造、加工分野では、微生物由来のリパーゼが広く用いられている。しかし、これまで用いられてきたリパーゼは、トリグリセリドがもつ3つの脂肪酸のうち、1位及び3位に特異的に作用するもの、或いは、非特異的に作用するものであった。このため、特に高い生理活性機能を有する高度不飽和脂肪酸の多くが位置する2位を交換・修飾することが困難であった。 Lipases are known as enzymes that act on the degradation and synthesis of fats and oils, and lipases derived from microorganisms are widely used in the production and processing fields of various fats and oils. However, the lipase used so far has been one that specifically acts on the 1st and 3rd positions among the three fatty acids of triglycerides, or one that acts nonspecifically. For this reason, it has been difficult to exchange and modify the 2-position where many of the highly unsaturated fatty acids having particularly high bioactive functions are located.
本発明は、上記事項に鑑みてなされたものであり、その目的とするところは、グリセロールの2位に対して優先的に触媒作用を有し、2位に高度不飽和脂肪酸を結合させて機能性脂質の合成に資するリパーゼを提供することにある。 The present invention has been made in view of the above-mentioned matters, and the object of the present invention is to preferentially act on the 2-position of glycerol and to function by binding a highly unsaturated fatty acid to the 2-position. It is to provide a lipase that contributes to the synthesis of sex lipids.
本発明に係るリパーゼは、
モルティエレラ属SAM2197株(FERM BP−6261)により生産され、グリセロールの2位に対して優先的に触媒作用を有し、分子量が11kDaである。
The lipase according to the present invention is
Produced by Mortierella SAM2197 strain (FERM BP-6261), preferentially have a catalytic effect on the 2-position of glycerol, a molecular weight of 11 kDa.
また、至適pHが8〜10であることが望ましい。 Moreover, it is desirable that optimal pH is 8-10.
また、至適温度が45〜55℃であることが望ましい。 Further, it is desirable that the optimum temperature is 45 to 55 ° C.
また、前記モルティエレラ属SAM2197株を培養して120〜168時間後に回収し、精製して得られることが好ましい。 The Mortierella sp. SAM2197 strain is preferably cultured and then collected after 120 to 168 hours and purified.
本発明に係る機能性脂質の合成方法は、
グリセロールと高度不飽和脂肪酸とに上記に記載のリパーゼを介在させ、2−モノグリセリドを合成する工程を含むことを特徴とする。
The method for synthesizing a functional lipid according to the present invention includes:
It includes a step of synthesizing 2-monoglyceride by interposing the lipase described above in glycerol and a highly unsaturated fatty acid.
また、前記高度不飽和脂肪酸としてアラキドン酸(Arachidonic acid)、エイコサペンタエン酸(Eicosapentaenoic acid)、ドコサヘキサエン酸(Docosahexaenoic acid)及びジホモ−γ−リノレン酸(Dihomo−gamma−linolenic acid)から選択される一種以上を用いることが好ましい。 The polyunsaturated fatty acid may be selected from arachidonic acid, eicosapentaenoic acid, docosahexaenoic acid, and dihomo-γ-linolenic acid (Dihomomo-gamma-linolenic acid). Is preferably used.
本発明に係るリパーゼは、グリセロールと脂肪酸とに介在させることで、グリセロールの2位に優先的に作用する特性を有しており、高い生理機能を有する機能性脂質を合成することができる。 The lipase according to the present invention has a property of acting preferentially at the 2-position of glycerol by intervening between glycerol and fatty acid, and can synthesize functional lipids having high physiological functions.
本実施の形態に係るリパーゼは、糸状菌モルティエレラ(Mortierella)属モルティエレラ(Mortierella)亜属に属するSAM2197株(FERM BP−6261)により生産されるリパーゼである。このリパーゼは、トリグリセロール(1,2,3−プロパントリオール)の2位に対し、優先的に触媒作用を発揮する。 The lipase according to the present embodiment is a lipase produced by the SAM2197 strain (FERM BP-6261) belonging to the genus Mortierella (Mortierella). This lipase preferentially exerts a catalytic action on the 2-position of triglycerol (1,2,3-propanetriol).
また、このリパーゼは、以下の特徴を有する。
分子量:11kDa
至適pH:8〜10
至適温度:45〜55℃
Moreover, this lipase has the following characteristics.
Molecular weight: 11 kDa
Optimum pH: 8-10
Optimal temperature: 45-55 ° C
本実施の形態に係るリパーゼは、SAM2197株を培養することで生産されるが、SAM2197株の培養は、一例として以下に示す培養条件及び培養方法で行うことができる。 The lipase according to the present embodiment is produced by culturing the SAM2197 strain. The SAM2197 strain can be cultured by the following culture conditions and culture methods as an example.
SAM2197株の胞子、菌糸、又は予め培養して得られた培養液を、液体培地又は固体培地に接種し培養することができる。液体培地の場合、炭素源としてはグルコース、フラクトース、キシロース、サッカロース、マルトース、可溶性デンプン、糖蜜、グリセロール、マンニトール、クエン酸、コーンスターチ等の一般的に使用されているものがいずれも使用できるが、特にグルコース、フラクトース、マルトース、グリセロール、クエン酸、コーンスターチが好ましい。窒素源としてはペプトン、酵母エキス、麦芽エキス、肉エキス、カザミノ酸、コーンスティープリカー、大豆タンパク等の天然窒素源の他に、尿素等の有機窒素源、ならびに硝酸ナトリウム、硝酸アンモニウム、硫酸アンモニウム等の無機窒素源等の一般的に使用されているものを用いることができる。この他必要に応じて微量栄養源として用いる、リン酸カリウム、リン酸二水素カリウム等のリン酸塩、硫酸アンモニウム、硫酸ナトリウム、硫酸マグネシウム、硫酸鉄、硫酸銅、塩化マグネシウム、塩化カリウム等の無機塩及びビタミン等全て一般的に使用されているものが使用できる。 The spore, mycelium of SAM2197 strain, or a culture solution obtained by culturing in advance can be inoculated into a liquid medium or a solid medium and cultured. In the case of a liquid medium, any carbon source commonly used such as glucose, fructose, xylose, saccharose, maltose, soluble starch, molasses, glycerol, mannitol, citric acid, corn starch, etc. can be used. Glucose, fructose, maltose, glycerol, citric acid and corn starch are preferred. Nitrogen sources include natural nitrogen sources such as peptone, yeast extract, malt extract, meat extract, casamino acid, corn steep liquor, and soy protein, organic nitrogen sources such as urea, and inorganics such as sodium nitrate, ammonium nitrate, and ammonium sulfate. Commonly used materials such as a nitrogen source can be used. Other inorganic salts such as potassium phosphate, potassium dihydrogen phosphate, etc., ammonium sulfate, sodium sulfate, magnesium sulfate, iron sulfate, copper sulfate, magnesium chloride, potassium chloride, etc. In addition, all commonly used vitamins can be used.
本実施の形態に係るリパーゼは、SAM2197株を培地中で培養して120〜168時間経過後に回収し、精製されていることが好ましい。好ましくは、培養時間が132〜156時間、より好ましくは144時間である。 The lipase according to the present embodiment is preferably purified by culturing the SAM2197 strain in a medium and collecting it after 120 to 168 hours. The culture time is preferably 132 to 156 hours, more preferably 144 hours.
なお、リパーゼの精製は一例として、以下のようにして行うことができる。培養後、培養物をフィルターで濾過し、菌体と培養上清を得る。菌体はヘキサンで軽く洗浄して、表面の油脂を除去した後、20mM Tris−HCl,pH9.0(以下、TBと記す)に懸濁して、氷上でガラスビーズとともにホモジナイズして破砕する。不溶性成分を遠心分離(10,000rpm,15min)で除去し、その上清を新たな試験管に移し、冷アセトンを50%となるように加えて4時間冷却し、遠心分離(10,000rpm,10min)により活性成分を沈殿回収する。培養上清も同様に処理して、沈殿に活性成分を回収する。これらをTBに溶解させ、同緩衝液に対して透析する。不溶性物質を遠心分離で除去した後、TBで平衡化したDEAE−Sepharoseカラム(5ml,GE Healthcare)にかける。0−2M NaClを含むTBを用いてグラジエント溶出を行い、活性画分を集める。これを、1M硫酸アンモニウムを含むTBで平衡化したphenyl−Sepharose Fast Flowカラム(1ml,GE Healthcare)にかけ、カラムを十分に洗浄した後、0−1M硫酸アンモニウムを含むTBでグラジエント溶出する。活性成分がまだ吸着している場合は、1−1.5%CHAPS(3−[(3−cholamidopropyl)dimethylammonio]propanesulfonate)を含むTBで溶出させる。集めた活性画分をTBに対して透析し、遠心した後、Superdex 200カラム(HR 10/30,GE Healthcare)にかけ、0.15M NaClを含むTBで溶出する。このようにしてリパーゼを精製することができる。 The lipase can be purified as follows as an example. After culture, the culture is filtered through a filter to obtain bacterial cells and culture supernatant. The bacterial cells are washed lightly with hexane to remove oils and fats on the surface, suspended in 20 mM Tris-HCl, pH 9.0 (hereinafter referred to as TB), homogenized with glass beads on ice and crushed. Insoluble components were removed by centrifugation (10,000 rpm, 15 min), the supernatant was transferred to a new test tube, cold acetone was added to 50%, cooled for 4 hours, and centrifuged (10,000 rpm, 10 minutes), the active ingredient is recovered by precipitation. The culture supernatant is treated in the same manner, and the active ingredient is recovered in the precipitate. These are dissolved in TB and dialyzed against the same buffer. Insoluble material is removed by centrifugation and then applied to a DEAE-Sepharose column (5 ml, GE Healthcare) equilibrated with TB. Gradient elution is performed using TB containing 0-2M NaCl, and the active fraction is collected. This is applied to a phenyl-Sepharose Fast Flow column (1 ml, GE Healthcare) equilibrated with TB containing 1M ammonium sulfate, and the column is washed thoroughly, and then gradient elution is performed with TB containing 0-1M ammonium sulfate. If the active ingredient is still adsorbed, it is eluted with TB containing 1-1.5% CHAPS (3-[(3-cholamidopropyl) dimethylaminosulfonate) sulfonate). The collected active fraction is dialyzed against TB, centrifuged, applied to a Superdex 200 column (HR 10/30, GE Healthcare), and eluted with TB containing 0.15 M NaCl. In this way, the lipase can be purified.
(機能性脂質の合成方法)
本実施の形態に係る機能性脂質の合成方法は、上述したリパーゼをグリセロールと脂肪酸とに介在させて2−モノグリセリドを合成する工程を含む。
(Method for synthesizing functional lipids)
The method for synthesizing a functional lipid according to the present embodiment includes a step of synthesizing 2-monoglyceride by interposing the above-described lipase between glycerol and a fatty acid.
機能性脂質として、例えば、グリセロールの2位にアラキドン酸(Arachidonic acid;AA)、エイコサペンタエン酸(Eicosapentaenoic acid;EPA)、ドコサヘキサエン酸(Docosahexaenoic acid;DHA)等の高度不飽和脂肪酸が結合した2−モノグリセリドが挙げられる。 As a functional lipid, for example, a 2-unsaturated fatty acid such as arachidonic acid (AA), eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and the like is bonded to the 2-position of glycerol. A monoglyceride is mentioned.
グリセロールと上記高度不飽和脂肪酸とにリパーゼを介在させることで、リパーゼがグリセロールの2位に位置する水酸基と、高度不飽和脂肪酸のカルボキシル基とのエステル結合を優先的に生じさせる。これにより、上述した2−モノグリセリドを合成することができる。 By interposing lipase between glycerol and the above highly unsaturated fatty acid, the lipase preferentially generates an ester bond between the hydroxyl group located at the 2-position of glycerol and the carboxyl group of the highly unsaturated fatty acid. Thereby, the 2-monoglyceride mentioned above is compoundable.
高度不飽和脂肪酸がグリセロールの2位に結合した機能性脂質は、生物に対して生理的活性を与えうる。 A functional lipid in which a highly unsaturated fatty acid is bonded to the 2-position of glycerol can impart physiological activity to an organism.
なお、グリセロールの2位のほか、1位及び3位に脂肪酸が結合した場合、特異的に1,3−リパーゼ等の酵素で、1位及び3位に結合した脂肪酸を加水分解し、2−モノグリセリドを得てもよい。 In addition, when a fatty acid is bonded to the 1st and 3rd positions in addition to the 2nd position of glycerol, the fatty acid bonded to the 1st and 3rd positions is hydrolyzed with an enzyme such as 1,3-lipase specifically, Monoglycerides may be obtained.
また、リパーゼを用いて低温でグリセロールの2位に高度不飽和脂肪酸を結合させた場合、生成するモノグリセリドが析出し、リパーゼ反応の系外に出されるため、2−モノグリセリドを得ることができる。 In addition, when a highly unsaturated fatty acid is bonded to the 2-position of glycerol at a low temperature using lipase, the resulting monoglyceride is precipitated and discharged out of the lipase reaction system, so that 2-monoglyceride can be obtained.
また、同様の反応において、減圧下で水分量を一定範囲に制限すると、モノグリセリドからジグリセリドを合成する活性が低下するため、2−モノグリセリドを選択的に得ることができる(Watanabe Y.et al.,Journal of American Oil Chemists Society,82,619−623,2005)。 Further, in the same reaction, when the water content is limited to a certain range under reduced pressure, the activity of synthesizing diglyceride from monoglyceride is reduced, so that 2-monoglyceride can be selectively obtained (Watanabe Y. et al.,). Journal of American Oil Chemistry Society, 82, 619-623, 2005).
以下、実施例に基づいて、本実施の形態に係るリパーゼ、及び、これを用いた機能性脂質の合成方法について詳細に説明する。 Hereinafter, based on an Example, the lipase which concerns on this Embodiment, and the synthesis method of a functional lipid using the same are demonstrated in detail.
以下の実施例において、monocaprylin、monopamitin、monoolein、monolinolein、monolinoleninは、シグマ−アルドリッチ株式会社製を用いた。dicaprylin、diolein、dilinoleinは、フナコシ株式会社製を用いた。その他のトリアシルグリセロール及び脂肪酸エステルは、和光純薬株式会社製を用いた。 In the following examples, monocaprylin, monopamitin, monoolein, monolinolein, monolinolein, manufactured by Sigma-Aldrich Corporation was used. As for dicaprylin, diolein and dilinolein, those manufactured by Funakoshi Co., Ltd. were used. Other triacylglycerols and fatty acid esters were manufactured by Wako Pure Chemical Industries, Ltd.
まず、SAM2197株を、50mLの基本培地(0.5%glucose,1%soybean powder,0.3%KH2PO4,0.1%Na2SO4,0.05%CaCl2・2H2O,0.05%MgCl2・6H2O,0.01%antifoam,pH7.0)を用い、28℃、160rpmの条件下で培養した。 First, SAM2197 strain was added to 50 mL of basic medium (0.5% glucose, 1% soybean powder, 0.3% KH 2 PO 4 , 0.1% Na 2 SO 4 , 0.05% CaCl 2 .2H 2 O). , 0.05% MgCl 2 · 6H 2 O, 0.01% antifoam, pH 7.0), and cultured at 28 ° C. and 160 rpm.
培養開始後72時間後に1%となるようにアマニ油を加えた後、培養上清、菌体内可溶性画分及び膜画分のリパーゼ活性を追跡した。 Linseed oil was added to 1% 72 hours after the start of the culture, and then the lipase activity of the culture supernatant, the soluble fraction in the cell and the membrane fraction was followed.
リパーゼ活性は、以下のように、油水乳濁系で酢酸銅法によって測定した。まず、5%オリーブ油を含む50mMリン酸緩衝液(pH7.4)を10分間超音波処理した。この乳濁液1mLを、適当な容量(4mL程度)の培養上清、細胞抽出液或いは精製酵素溶液(20mM Tris−HCl、pH9.0)に加えて、37℃で1時間振盪しながらインキュベートした。反応は、1mLの塩酸と3.5mLのイソオクタンを加え、5分間煮沸することによって停止させた。 The lipase activity was measured by the copper acetate method in an oil-water emulsion system as follows. First, a 50 mM phosphate buffer solution (pH 7.4) containing 5% olive oil was sonicated for 10 minutes. 1 mL of this emulsion was added to an appropriate volume (about 4 mL) of culture supernatant, cell extract or purified enzyme solution (20 mM Tris-HCl, pH 9.0) and incubated at 37 ° C. for 1 hour with shaking. . The reaction was stopped by adding 1 mL hydrochloric acid and 3.5 mL isooctane and boiling for 5 minutes.
遊離脂肪酸を含む上層のイソオクタン相(3.5mL)を新たな試験管に移し、1mLの5%(w/v)酢酸銅水溶液(ピリジンでpH6.1に調整)を加えてよく混合した。1分間遠心し、上層を新たな試験管に移して、溶媒を蒸発除去した。 The upper isooctane phase (3.5 mL) containing free fatty acid was transferred to a new test tube, and 1 mL of 5% (w / v) aqueous copper acetate solution (adjusted to pH 6.1 with pyridine) was added and mixed well. After centrifuging for 1 minute, the upper layer was transferred to a new test tube, and the solvent was removed by evaporation.
脂肪酸は100μLのイソオクタンに溶解させ、715nmにおける吸光度を測定して、オレイン酸標準物質との比較で、1μmoleの脂肪酸が1時間に生成した場合を1Uとした。 The fatty acid was dissolved in 100 μL of isooctane, the absorbance at 715 nm was measured, and the case where 1 μmole of fatty acid was produced in 1 hour was defined as 1 U in comparison with the oleic acid standard substance.
図1にリパーゼ活性の追跡結果を示す。図1をみると、96時間後には、培養上清、菌体内可溶性画分及び菌体内膜画分の全ての活性が消失したが、144時間後には上清で753U/ml、菌体可溶性画分で276U/mlの最大活性が得られた。なお、菌体内膜画分には活性がわずかしか検出されなかった。 FIG. 1 shows the results of tracking lipase activity. As shown in FIG. 1, after 96 hours, all the activities of the culture supernatant, the intracellular soluble fraction and the intracellular membrane fraction were lost, but after 144 hours, the supernatant was 753 U / ml and the bacterial cell soluble. A maximum activity of 276 U / ml was obtained in the fraction. Only a small amount of activity was detected in the cell membrane fraction.
菌体内リパーゼに着目し、最大活性を示した培養時間に菌体を回収し、リパーゼを精製した。 Focusing on the intracellular lipase, the bacterial cells were collected at the culture time showing the maximum activity, and the lipase was purified.
精製リパーゼは以下のようにして得た。培養6日目(培養開始から144時間)の培養物をフィルター(東洋濾紙No.2)で濾過し、菌体と培養上清を得た。 Purified lipase was obtained as follows. The culture on the 6th day of culture (144 hours from the start of culture) was filtered through a filter (Toyo Filter Paper No. 2) to obtain cells and culture supernatant.
菌体はヘキサンで軽く洗浄して、表面の油脂を除去した後、20mM Tris−HCl,pH9.0(以下、TBと記す)に懸濁して、氷上でガラスビーズとともにホモジナイズして破砕した。遠心分離(10,000rpm,15min)により不溶性成分を除去した。 The cells were lightly washed with hexane to remove oils and fats on the surface, suspended in 20 mM Tris-HCl, pH 9.0 (hereinafter referred to as TB), homogenized with glass beads on ice and crushed. Insoluble components were removed by centrifugation (10,000 rpm, 15 min).
上清を新たな試験管に移し、冷アセトンを50%となるように加えて4時間冷却し、遠心分離(10,000rpm,10min)により活性成分を沈殿回収した。 The supernatant was transferred to a new test tube, cold acetone was added to a concentration of 50%, the mixture was cooled for 4 hours, and the active ingredient was collected by centrifugation (10,000 rpm, 10 min).
培養上清も同様に処理して、沈殿に活性成分を回収した。 The culture supernatant was treated in the same manner, and the active ingredient was recovered in the precipitate.
これらをTBに溶解し、同緩衝液に対して透析した。不溶性物質を遠心分離で除去した後、TBで平衡化したDEAE−Sepharoseカラム(5mL,GE Healthcare)にかけた。0−2M NaClを含むTBを用いてグラジエント溶出を行い、活性画分を集めた。 These were dissolved in TB and dialyzed against the same buffer. Insoluble material was removed by centrifugation and then applied to a DEAE-Sepharose column (5 mL, GE Healthcare) equilibrated with TB. Gradient elution was performed using TB containing 0-2M NaCl, and the active fractions were collected.
この活性画分を、1M硫酸アンモニウムを含むTBで平衡化したphenyl−Sepharose Fast Flowカラム(1mL,GE Healthcare)にかけ、カラムを十分に洗浄した後、0−1M硫酸アンモニウムを含むTBでグラジエント溶出した。この際に、活性成分はまだ吸着していたので、1−1.5%CHAPS(3−[(3−cholamidopropyl)dimethylammonio]propanesulfonate)を含むTBで溶出させた。 This active fraction was applied to a phenyl-Sepharose Fast Flow column (1 mL, GE Healthcare) equilibrated with TB containing 1M ammonium sulfate, and the column was thoroughly washed, and then eluted with TB containing 0-1M ammonium sulfate. At this time, since the active ingredient was still adsorbed, it was eluted with TB containing 1-1.5% CHAPS (3-[(3-cholamidopropylo) dimethylaminosulfonate).
集めた活性画分をTBに対して透析し、遠心した。その後、Superdex200カラム(HR 10/30,GE Healthcare)にかけ、0.15M NaClを含むTBで溶出した。 The collected active fractions were dialyzed against TB and centrifuged. Then, it was applied to a Superdex 200 column (HR 10/30, GE Healthcare) and eluted with TB containing 0.15 M NaCl.
なお、精製ステップを表1に示す。精製の各段階において、回収した活性画分以外にはリパーゼ活性は認められなかった。
The purification steps are shown in Table 1. At each stage of purification, no lipase activity was observed other than the recovered active fraction.
上述のようにして得られた精製リパーゼについてゲル濾過を行った。その結果を図2に示す。図2中、Voはボイド容積、Tvは全カラム容積、各数値はマーカータンパク質の分子量(kDa)である。図2をみると、破線で示すUV吸収(280nm)の吸収ピークと一致する活性ピークがボイド画分(>1,300kDa)に認められる。 The purified lipase obtained as described above was subjected to gel filtration. The result is shown in FIG. In FIG. 2, Vo is the void volume, Tv is the total column volume, and each numerical value is the molecular weight (kDa) of the marker protein. When FIG. 2 is seen, the active peak which corresponds with the absorption peak of UV absorption (280 nm) shown with a broken line is recognized by a void fraction (> 1,300 kDa).
また、MALDI−TOF−MS(Ultraflex TOF/TOF;Bruker Daltonics)解析を行った。MALDI−TOF−MS解析は、精製リパーゼ1ngを用い、以下の条件でおこなった。
リニアモード/ポジティブ,
加速電圧=25kV,
MALDIマトリックス=2,5−dihydroxybenzoic acid,
キャリブレーション=外部
Moreover, MALDI-TOF-MS (Ultraflex TOF / TOF; Bruker Daltonics) analysis was performed. MALDI-TOF-MS analysis was performed using 1 ng of purified lipase under the following conditions.
Linear mode / positive,
Acceleration voltage = 25 kV,
MALDI matrix = 2,5-dihydroxybenzoic acid,
Calibration = external
その結果を図3に示す。図3を見ると、マイナーなピークとともに、10,965Daのマスシグナルが認められる。 The result is shown in FIG. When FIG. 3 is seen, the mass signal of 10,965 Da is recognized with a minor peak.
以上のゲル濾過及びMALDI−TOF−MS解析結果から、精製リパーゼの分子量は約11kDaであることがわかる。 From the above gel filtration and MALDI-TOF-MS analysis results, it can be seen that the molecular weight of the purified lipase is about 11 kDa.
続いて、精製リパーゼの活性及び安定性におけるpHの影響を検証した。 Subsequently, the effect of pH on the activity and stability of purified lipase was verified.
精製リパーゼ(34μg/mL)の37°Cにおけるリパーゼ活性を、オリーブ油を基質とする各種50mM緩衝液(glycine−HCl,pH2;acetate buffer,pH3−6;phosphate buffer,pH6−7;Tris−HCl,pH8−9;glycine−NaOH,pH9−12)中で、それぞれ測定した。 The lipase activity of purified lipase (34 μg / mL) at 37 ° C. was determined using various 50 mM buffers (glycine-HCl, pH 2; acetate buffer, pH 3-6; phosphate buffer, pH 6-7; Tris-HCl, olive oil as a substrate). pH 8-9; glycine-NaOH, pH 9-12).
また、精製リパーゼのpHに対する安定性を検証するため、精製リパーゼを上記各緩衝液中で4°C,24時間インキュベートした後に、リパーゼ活性を測定した。 In order to verify the stability of the purified lipase with respect to pH, the purified lipase was incubated at 4 ° C. for 24 hours in the respective buffers, and then the lipase activity was measured.
その結果を図4に示す。図4をみると、精製リパーゼはpH2−12の範囲で酵素活性を維持している。また、至適pHは8〜10であり、特にpH9で最も良好であった。このような幅広いpHで活性を維持する特性は、P.caseicolum、P.crustosum、P.rouqueforti、Bysoochlamys verrucosaなどのわずかな例を除いては珍しく、ほとんどのリパーゼは酸性側が至適pHである。このことから、精製リパーゼは広範囲のpH条件下で用い得る。また、24時間インキュベートした後の酵素活性(安定性)についても、上記とほぼ同様の傾向を示し、幅広いpHで活性を維持していることがわかる。 The result is shown in FIG. As shown in FIG. 4, the purified lipase maintains the enzyme activity in the range of pH 2-12. Further, the optimum pH was 8 to 10, and the best value was especially at pH 9. The property of maintaining activity in such a wide pH range is P.I. caseicolum, P.M. crustosum, P.M. Unusual except for a few examples such as roqueforti and Bysochochlamys verrucosa, most lipases have an optimum pH on the acidic side. Thus, purified lipase can be used under a wide range of pH conditions. In addition, the enzyme activity (stability) after 24 hours of incubation also shows a tendency similar to that described above, indicating that the activity is maintained over a wide pH range.
続いて、精製リパーゼの活性及び安定性に与える温度の影響を検証した。 Subsequently, the effect of temperature on the activity and stability of purified lipase was verified.
精製リパーゼ(34μg/mL)の50mMリン酸緩衝液(pH7.4)におけるリパーゼ活性を、オリーブ油を基質として、種々の温度下で測定した。 Lipase activity in purified lipase (34 μg / mL) in 50 mM phosphate buffer (pH 7.4) was measured at various temperatures using olive oil as a substrate.
また、精製リパーゼの温度に対する安定性を検証するため、精製リパーゼを各温度で1時間インキュベートした後、リパーゼ活性を測定した。 Further, in order to verify the stability of purified lipase with respect to temperature, the purified lipase was incubated at each temperature for 1 hour, and then lipase activity was measured.
図5にその結果を示す。図5をみると、精製リパーゼは、20−80°Cの反応条件下で活性を維持していた。至適温度は45〜55℃であり、50℃で最も良好な活性を示している。なお、70°C以上で1時間以上保持した場合は失活した。これまでのほとんどのリパーゼは40°C以下が至適温度であり、50°C或いは60°C以上ではリパーゼ活性がなかったことからすると、精製リパーゼは特徴的であり、広範囲の温度条件下で使用が可能である。 FIG. 5 shows the result. Referring to FIG. 5, the purified lipase maintained activity under the reaction conditions of 20-80 ° C. The optimum temperature is 45 to 55 ° C, and the best activity is shown at 50 ° C. In addition, when it kept at 70 degreeC or more for 1 hour or more, it deactivated. Most conventional lipases have an optimum temperature of 40 ° C or lower, and no lipase activity at 50 ° C or 60 ° C or higher. Thus, purified lipase is characteristic and can be used under a wide range of temperature conditions. Can be used.
精製リパーゼの基質特異性を調べるため、異なるアシル鎖長や不飽和結合数の脂肪酸をもつモノアシルグリセロール(以下、MAGとも記す)、ジアシルグリセロール(以下、DAGとも記す)、トリアシルグリセロール(以下、TAGとも記す)、及び、脂肪酸エステルの加水分解活性を測定した。 In order to examine the substrate specificity of purified lipase, monoacylglycerol (hereinafter also referred to as MAG), diacylglycerol (hereinafter also referred to as DAG), triacylglycerol (hereinafter referred to as DAG) having fatty acids having different acyl chain lengths and unsaturated bond numbers. And also the hydrolysis activity of fatty acid esters.
1mMのトリアシルグリセロール、モノアシルグリセロール、天然植物油、リン脂質、及び、2mMの脂肪酸メチルエステルに対する加水分解活性を、加水分解によって遊離した遊離脂肪酸を定量することにより行った。なお、それぞれの基質について、30℃及び50℃の条件下での活性を測定した。 Hydrolysis activity for 1 mM triacylglycerol, monoacylglycerol, natural vegetable oil, phospholipid, and 2 mM fatty acid methyl ester was performed by quantifying free fatty acids released by hydrolysis. In addition, about each substrate, the activity on 30 degreeC and 50 degreeC conditions was measured.
その結果を図6に示す。30℃又は50°Cで、或いはその両方で、各種MAGやTAGに対して活性が認められたが、DAGに関しては不図示の1,3−dicaprylin、1,3−dipalmitin、1,2−diolein、1,3−diolein、1,2−dilinoleinにおいて、いずれの温度でも活性は検出されなかった。 The result is shown in FIG. Although activity against various MAGs and TAGs was observed at 30 ° C. and / or 50 ° C., 1,3-dicaprylin, 1,3-dipalmitin, 1,2-diolein not shown for DAG No activity was detected at any temperature in 1,3-diolein and 1,2-dilineolein.
飽和脂肪酸をもつTAGに対して30°Cで活性がなかったのは、基質の融点が低いことから同温度では溶解していないためと考えられる。不飽和脂肪酸の遊離活性はTAGよりもMAGにおいて高く、アシル鎖の不飽和度に依存していた。 The reason why there was no activity at 30 ° C. with respect to TAG having saturated fatty acid is considered to be because it was not dissolved at the same temperature because the melting point of the substrate was low. The release activity of unsaturated fatty acids was higher in MAG than in TAG and was dependent on the degree of unsaturation of the acyl chain.
なかでも、1−monolinoleninが最も高い値を示した。2−monooleinと2−monolinoleinは、それぞれ1−monooleinと1−monolinoleinよりも高い活性を与えた。 Among them, 1-monoolinolenin showed the highest value. 2-monoolein and 2-mononolinein gave higher activities than 1-monoolein and 1-mononolinein, respectively.
一方、それぞれ不図示のmethylbutyrate、methyllaurate、methylpalmitate、methylpamitoleate、methylsterate、methyllinoleate、methyllinolenate、methyleicosapentaenoateなどの脂肪酸メチルエステルに対しては、30℃及び50°Cにおいて活性が検出されず、methylcaprylateとmethyloleateでは50°Cでのみ検出された。 On the other hand, fatty acid methyl esters such as methylbutyrate, methyllaureate, methylpalmateate, methylpalylateate, methylesterate, methyllinoleate, methyllinolenate, and thiylamineate, which are not shown in the figure, are in the form of 50 degrees centigrade. Only C was detected.
天然植物油では、キャメリア油(Camellia oil)が最も高い活性を与えた。これは不飽和脂肪酸を多く含む(〜86%oleic acid)ためであると考えられる。 Among natural vegetable oils, camelia oil gave the highest activity. This is considered to be because it contains a lot of unsaturated fatty acids (˜86% oleic acid).
オリーブ油(Olive oil)とアマニ油(Linseed oil)はほとんど差がなかった。興味深いことに、卵黄ホスファチジルコリン(Phosphatidylcholine)に対して高い活性を示した。これは真菌由来リパーゼでは極めて珍しく、他起源のリパーゼではアシルグリセロールとリン脂質の両方に対して作用することはない。 There was little difference between olive oil and linseed oil. Interestingly, it showed high activity against egg yolk phosphatidylcholine. This is extremely rare in fungal lipases, and lipases from other sources do not act on both acylglycerols and phospholipids.
(アシルグリセロールの加水分解)
オレイン酸のみを持つ種々のアシルグリセロールからのリパーゼ作用による加水分解物について、脂質組成を調べた。
(Acylglycerol hydrolysis)
Lipid compositions of hydrolysates by lipase action from various acylglycerols having only oleic acid were examined.
100mgの各種基質と、1mLの精製リパーゼ(10U)と、1mLの50mMリン酸緩衝液(pH7.4)とからなる反応液を30°Cで1時間、170rpmで撹拌しながらインキュベートした。生成物を以下のように分離し、定量した。 A reaction solution consisting of 100 mg of various substrates, 1 mL of purified lipase (10 U), and 1 mL of 50 mM phosphate buffer (pH 7.4) was incubated at 30 ° C. for 1 hour with stirring at 170 rpm. The product was separated and quantified as follows.
脂質の組成はシリカゲルプレート(Kieselgel 60;Merck)を用いた薄層クロマトグラフィーによって同定及び定量した。MAG異性体をより良く分離する場合は、プレートを3%シュウ酸に浸して、一晩乾燥したものを用いた。展開溶媒として、それぞれヘキサン/エーテル/酢酸(70:30:1,v/v)あるいはクロロホルム/アセトン/酢酸(96:4:1,v/v)を用いた。脂質は2%硫酸銅/13%硫酸溶液あるいは50%硫酸メタノール溶液を噴霧して、140°Cで加熱することにより可視化した。 Lipid composition was identified and quantified by thin layer chromatography using silica gel plates (Kieselgel 60; Merck). For better separation of MAG isomers, plates were soaked in 3% oxalic acid and dried overnight. As developing solvents, hexane / ether / acetic acid (70: 30: 1, v / v) or chloroform / acetone / acetic acid (96: 4: 1, v / v) was used, respectively. Lipids were visualized by spraying with 2% copper sulfate / 13% sulfuric acid solution or 50% methanol sulfate solution and heating at 140 ° C.
その結果を表2に示す。
The results are shown in Table 2.
Trioleinを基質とした場合、1,2−DAG及び1,3−DAG(それぞれ8.5%及び1.9%)ならびに遊離脂肪酸(FFA:Free Fatty Acid)(9.8%)が生成したが、MAGはなかった。これは、精製リパーゼがTAGの1/3位に対して効率的に作用すること、ならびに、DAGの加水分解が律速であることを示唆している。 When Triolein was used as a substrate, 1,2-DAG and 1,3-DAG (8.5% and 1.9%, respectively) and free fatty acid (FFA) (9.8%) were produced. There was no MAG. This suggests that purified lipase acts efficiently on the 1/3 position of TAG and that DAG hydrolysis is rate limiting.
1,2−Diolein及び1,3−Dioleinの加水分解では、Trioleinで示したような脂肪酸は遊離されず、両DAG間での異性化も認められなかった。しかし、1,2−Dioleinに限っては、TAGの生成(41%)が見られた。 In the hydrolysis of 1,2-Diolein and 1,3-Diolein, fatty acids as shown by Triolein were not liberated and no isomerization was observed between both DAGs. However, TAG generation (41%) was observed only for 1,2-Diolein.
1−Monooleinは2−Monooleinよりもよく加水分解され、脂肪酸遊離量の比はおよそ2:1であった。これは図6に示した結果とほぼ一致した。いずれの場合もDAGは検出されなかったが、2−monooleinの方だけにTAGの生成(29%)が認められた。 1-Monoolein was hydrolyzed better than 2-Monoolein, and the fatty acid release ratio was approximately 2: 1. This almost coincided with the result shown in FIG. In either case, DAG was not detected, but only 2-monoolein produced TAG (29%).
以上の結果は、2−Monooleinから遊離された脂肪酸が2−MAGに再び取り込まれてTAGを生成したことを示唆している。 The above results suggest that the fatty acid released from 2-Monoolein was re-incorporated into 2-MAG to produce TAG.
(アシルグリセロールの合成)
精製リパーゼを触媒として、グリセロールとオレイン酸からアシルグリセロールの合成を、以下のようにして行った。1.8mlのグリセロール/オレイン酸混合液(7:1,v/v)と0.2mlの精製リパーゼ(20U)からなる反応液を、120min,37°Cで振盪しながらインキュベートした。
(Synthesis of acylglycerol)
Using purified lipase as a catalyst, acylglycerol was synthesized from glycerol and oleic acid as follows. A reaction solution consisting of 1.8 ml of a glycerol / oleic acid mixture (7: 1, v / v) and 0.2 ml of purified lipase (20 U) was incubated for 120 min at 37 ° C. with shaking.
生成物をクロロホルムで抽出して、薄層クロマトグラフィーで脂質組成の分析を行い、脂質組成の経時変化を追跡した。その結果を図7に示す。 The product was extracted with chloroform, the lipid composition was analyzed by thin layer chromatography, and the time course of the lipid composition was followed. The result is shown in FIG.
図7を見ると、反応初期では、ほぼ同モル量の1−MAG及び2−MAGが生成したが、1,2−DAG及び1,3−DAGは少量蓄積した後、減少に転じた。1−MAGは最終的に14.5%に達した。 Referring to FIG. 7, at the initial stage of the reaction, approximately the same molar amounts of 1-MAG and 2-MAG were produced, but 1,2-DAG and 1,3-DAG accumulated to a small amount and then turned to decrease. 1-MAG finally reached 14.5%.
一方、TAGは2−MAGの減少に対応して増加し、最終的に22%となった。これは2−MAGの1,3位への脂肪酸付加によりTAGが増加したものと考えられる。 On the other hand, TAG increased corresponding to the decrease of 2-MAG and finally reached 22%. This is thought to be due to the increase in TAG due to the addition of fatty acids at positions 1 and 3 of 2-MAG.
また、2−MAG、1,2−DAG、1,3−DAG、TAGの合計組成(26%)は、1−MAGの組成(15%)に対して2倍程度高く、精製リパーゼはグリセロールの2位に脂肪酸を直接付加する活性が高いことを示している。 The total composition of 2-MAG, 1,2-DAG, 1,3-DAG and TAG (26%) is about twice as high as that of 1-MAG (15%), and the purified lipase is glycerol. This indicates that the activity of directly adding a fatty acid at the 2-position is high.
精製リパーゼは2−MAG及び1,2−DAGを主に経由する生合成経路にて作用しTAGを生成しており、また、グリセロールに対しては、溶媒非存在下でも2位に強く作用するという、極めて特徴的な性質を有しているといえる。そして、精製リパーゼは加水分解よりも合成をより強く促進する傾向がある。このようなことから、機能性を付与するために構造設計して作られる構造脂質の合成にも有用であると考えられる。 Purified lipase acts in the biosynthetic pathway mainly via 2-MAG and 1,2-DAG to produce TAG, and acts strongly on position 2 even in the absence of a solvent for glycerol. It can be said that it has extremely characteristic properties. And purified lipase tends to promote synthesis more strongly than hydrolysis. For this reason, it is considered useful for the synthesis of structured lipids produced by structural design to impart functionality.
モルティエレラ属SAM2197株により生産されたリパーゼは、グリセロールの2位に位置する水酸基と脂肪酸とのエステル結合を優先的に促進させる触媒作用を有する。2位に高度不飽和脂肪酸を有する高い生理機能をもつ機能性脂質の合成が容易になるので、高い生理機能を備える食品や飼料、医薬品等の製造分野での利用が期待される。 The lipase produced by Mortierella SAM2197 strain has a catalytic action that preferentially promotes the ester bond between a hydroxyl group located at the 2-position of glycerol and a fatty acid. Since it is easy to synthesize a functional lipid having a highly physiological function having a highly unsaturated fatty acid at the 2-position, it is expected to be used in the production field of foods, feeds, pharmaceuticals and the like having a high physiological function.
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2010110684A JP5648783B2 (en) | 2010-05-12 | 2010-05-12 | Novel lipase and method for synthesizing functional lipids using the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2010110684A JP5648783B2 (en) | 2010-05-12 | 2010-05-12 | Novel lipase and method for synthesizing functional lipids using the same |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2011234692A JP2011234692A (en) | 2011-11-24 |
JP5648783B2 true JP5648783B2 (en) | 2015-01-07 |
Family
ID=45323374
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2010110684A Active JP5648783B2 (en) | 2010-05-12 | 2010-05-12 | Novel lipase and method for synthesizing functional lipids using the same |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5648783B2 (en) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69840022D1 (en) * | 1997-03-04 | 2008-10-30 | Suntory Ltd | PROCESS FOR PREPARING HIGH TEMPERATURE FATTY ACIDS AND HIGH TEMPERATURE FATTY ACIDS CONTAINING LIPID |
JP4088097B2 (en) * | 2002-04-26 | 2008-05-21 | サントリー株式会社 | Method for producing highly unsaturated fatty acid-containing lipid |
-
2010
- 2010-05-12 JP JP2010110684A patent/JP5648783B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2011234692A (en) | 2011-11-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100523206C (en) | Process for producing fat comprising triglyceride containing highly unsaturated fatty acid | |
HUT76707A (en) | Refining oil compositions | |
Chakraborty et al. | Preparation of eicosapentaenoic acid concentrates from sardine oil by Bacillus circulans lipase | |
JPWO2006022356A1 (en) | Method for producing microbial fats and oils optionally containing diacylglycerol content and the fats and oils | |
JP5416861B2 (en) | Method for producing highly unsaturated fatty acid-containing fat with lipase | |
KR102172422B1 (en) | A method of increasing the content of triglycerides having saturated fatty acids at the sn-2 position in vegetable oil and a method of converting triglyceride having an unsaturated fatty acid at the sn-2 position to triglyceride having a saturated fatty acid at the sn-2 position | |
EP1981982B1 (en) | Microbial fermentation-based production of phospholipids containing long-chain polyunsaturated fatty acids as their constituents | |
US20070148746A1 (en) | Process for the enzymatic synthesis of triglycerides | |
JP4079516B2 (en) | Method for producing triglyceride | |
JP6715586B2 (en) | Method for producing highly unsaturated fatty acid | |
JP2007089522A (en) | Method for producing fatty acid composition containing specific highly unsaturated fatty acid in concentrated state | |
JP5648783B2 (en) | Novel lipase and method for synthesizing functional lipids using the same | |
JP2004285182A (en) | Glyceride and its manufacturing process | |
JP3813585B2 (en) | Method for producing diglyceride | |
JP3929890B2 (en) | Method for producing diglyceride | |
JP3931219B2 (en) | Process for producing highly unsaturated fatty acid-containing fats and oils | |
JP3853767B2 (en) | Conjugated fatty acid menthol ester and method for producing the same | |
JP3813584B2 (en) | Method for producing diglyceride | |
JP4510045B2 (en) | Method for purifying conjugated linoleic acid isomers and uses thereof | |
JP2000014392A (en) | Production of glyceride containing highly unsaturated fatty acid | |
JP7092460B2 (en) | Manufacturing method of structural fats and oils | |
JP5903214B2 (en) | Method for producing DHA-containing phosphatidylserine by microbial fermentation | |
JP2004331607A (en) | Polyglycerol ester of conjugated fatty acid and method for producing the same | |
JPH07274984A (en) | Method for concentrating docosahexaenoic acid glyceride | |
WO2011075802A1 (en) | Production of diacylglycerols by lipase - catalyzed hydrolysis of palm oil |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20130221 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20140715 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20140909 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20141021 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20141028 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5648783 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |